Sign in

CIK 0001484612

  • Accelerated filer
  • Smaller reporting company

Outset Medical, Inc.

Sign in to watch
Ticker
OM
Exchange
Nasdaq
Industry
Electromedical & Electrotherapeutic Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
200514392
Phone
+1 669-231-8200
Business address
3052 ORCHARD DRIVE, SAN JOSE, CA, 95134
Former names
Home Dialysis Plus, Ltd.
Open-market buys, last 90 days
$870,260
in 1 filing
Open-market sales, last 90 days
$28,997
in 2 filings

Net +$841,264. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 50 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-08-10 Ahmed Nabeel VP Finance Purchase +600 $37.15 $22K 15,189
2021-08-10 Ahmed Nabeel VP Finance Purchase +400 $37.11 $15K 15,589
2021-08-05 Ahmed Nabeel Chief Financial Officer Grant or award +8,398 14,589
2021-08-05 Ahmed Nabeel Chief Financial Officer Grant or award · Non-Qualified Stock Option (right to buy) +18,070 18,070
2021-08-02 Vazquez Martin Chief Operating Officer Exercise or conversion +5,000 $3.88 $19K 14,255
2021-08-02 Vazquez Martin Chief Operating Officer Sale −5,000 $40.71 $204K 9,255
2021-08-02 Vazquez Martin Chief Operating Officer Exercise or conversion · Non-Qualified Stock Option (right to buy) −5,000 63,489
2021-08-02 Trigg Leslie Chief Executive Officer Exercise or conversion +20,000 $2.93 $59K 270,257
2021-08-02 Trigg Leslie Chief Executive Officer Sale −20,000 $40.62 $812K 250,257
2021-08-02 Trigg Leslie Chief Executive Officer Exercise or conversion · Non-Qualified Stock Option (right to buy) −20,000 126,873
2021-07-16 Ahmed Nabeel Interim CFO Grant or award +1,575 1,575
2021-07-15 Brottem John L. General Counsel Exercise or conversion +3,500 $9.48 $33K 18,172
2021-07-15 Brottem John L. General Counsel Sale −3,500 $43.83 $153K 14,672
2021-07-15 Brottem John L. General Counsel Exercise or conversion · Performance Options (right to buy) −3,500 27,765
2021-07-01 Vazquez Martin Chief Operating Officer Exercise or conversion +6,000 $3.88 $23K 15,255
2021-07-01 Vazquez Martin Chief Operating Officer Sale −6,000 $49.24 $295K 9,255
2021-07-01 Vazquez Martin Chief Operating Officer Exercise or conversion +5,000 $3.88 $19K 14,255
2021-07-01 Vazquez Martin Chief Operating Officer Sale −5,000 $49.26 $246K 9,255
2021-07-01 Vazquez Martin Chief Operating Officer Exercise or conversion +5,000 $3.88 $19K 14,255
2021-07-01 Vazquez Martin Chief Operating Officer Sale −5,000 $49.24 $246K 9,255

Page 33 of 34 · 678 trades